Coronado Biosciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Coronado Biosciences Inc
TickerFBIO
CIK #0001429260
CUSIP34960Q307
SectorLife Sciences - Pharmaceutical Preparations
Address45 Rockefeller Plaza Suite 2000, New York, NY 10111
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Fortress Biotech Inc 2018-03-13 6.5 M Exemption: 506(b) · Remaining: $23,483,000 · Duration: One year or less · Commission: $521,360 · Revenue: Decline to Disclose
Coronado Biosciences Inc 2011-06-06 25.8 M Exemption: 506 · Minimum: $25,000 · Remaining: $2,980,472 · Duration: One year or less · Commission: $2,580,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001429260] 10-K
[0001429260] 10-Q
[0001429260] 3
[0001429260] 4
[0001429260] 8-K
[0001429260] D
[0001429260] SC 13D
[0001429260] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Highbridge Capital Management LLC Fortress Biotech Inc [2024-10-25] 0.0
Fortress Biotech Inc Journey Medical Corp [2022-08-17] 56.9
Vanguard Group Inc Fortress Biotech Inc [2022-02-10] 5.71
Nantahala Capital Management LLC Fortress Biotech Inc [2021-02-16] 0.3
BlackRock Inc Fortress Biotech Inc [2021-02-02] 5.0
Katz Daryl Fortress Biotech Inc [2020-12-28] 5.87
Opaleye Management Inc Fortress Biotech Inc [2019-11-22] 11.0
Fortress Biotech Inc Avenue Therapeutics Inc [2017-10-19] 33.1
Fortress Biotech Inc Checkpoint Therapeutics Inc [2017-05-26] 14.8
Fortress Biotech Inc Mustang Bio Inc [2017-05-26] 41.1
Fortress Biotech Inc National Holdings Corp [2016-05-09] 18.3
Rosenwald Lindsay A MD Fortress Biotech Inc [2016-01-28] 13.3
DAK Capital Inc Coronado Biosciences Inc [2014-11-17] 6.45
Katz Daryl Coronado Biosciences Inc [2014-11-17] 6.45
Weiss Michael S Coronado Biosciences Inc [2014-02-28] 15.0
FMR LLC Coronado Biosciences Inc [2013-03-11] 0.0
RA Capital Management LLC Coronado Biosciences Inc [2012-07-03] 7.3
Elliott Associates LP Coronado Biosciences Inc [2012-02-24] 7.9
Rosenwald Lindsay A MD Coronado Biosciences Inc [2012-02-14] 18.2
[2012-02-13] None
Form 3/4/5 Filer 2011 - 2026
Coronado Biosciences Inc
Jin David
Rosenwald Lindsay A MD
Weiss Michael S
Avenue Therapeutics Inc
Hoenlein Malcolm
Mustang Bio Inc
Lorenz Kevin
Klein Dov
Harvey Jimmie
Lobell J Jay
Checkpoint Therapeutics Inc
Lu Lucy
Journey Medical Corp
Rowinsky Eric K
Hunter Robyn
Avgerinos George
Opus Point Healthcare Innovations Offshore Fund Ltd
FBIO Acquisition Inc
Opus Point Partners LLC
National Holdings Corp
Origo Acquisition Corp
Horgan Kevin
Barrett David Jonathan
Weisman Harlan F
Ritter Dale
Beerman Noah D
Sandage Bobby W Jr PhD
Rogers Michael W
Cooper Glenn L MD
Elliott Associates LP
Hehenberger Karin M
Elliott International LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Rosenwald Lindsay A MD
Common stock, par value $0.001
2026-03-18 Grant 475,424 $0.00
Weiss Michael S
common stock, par value $0.001
2026-03-18 Grant 475,424 $0.00
Harvey Jimmie
common stock, par value $0.001
2026-01-01 Grant 27,322 $0.00
Lorenz Kevin
common stock, par value $0.001
2026-01-01 Grant 27,322 $0.00
Hoenlein Malcolm
Common Stock, par value $0.001
2026-01-01 Grant 27,322 $0.00
Lobell J Jay
common stock, par value $0.001
2026-01-01 Grant 27,322 $0.00
Klein Dov
common stock, par value $0.001
2026-01-01 Grant 27,322 $0.00
Jin David
Common Stock, par value $0.001
2025-10-01 Grant 2,711 $1.31 3,551
Jin David
Common Stock, par value $0.001
2025-04-01 Grant 5,000 $1.22 6,100
Weiss Michael S
common stock, par value $0.001
2025-01-01 Grant 454,153 $0.00
Lobell J Jay
common stock, par value $0.001
2025-01-01 Grant 49,383 $0.00
Klein Dov
common stock, par value $0.001
2025-01-01 Grant 49,383 $0.00
Lu Lucy
common stock, par value $0.001
2025-01-01 Grant 49,383 $0.00
Harvey Jimmie
common stock, par value $0.001
2025-01-01 Grant 49,383 $0.00
Lorenz Kevin
common stock, par value $0.001
2025-01-01 Grant 49,383 $0.00
Hoenlein Malcolm
Common Stock, par value $0.001
2025-01-01 Grant 49,383 $0.00
Rosenwald Lindsay A MD
Common stock, par value $0.001
2025-01-01 Grant 454,153 $0.00
Jin David
Common Stock, par value $0.001
2024-12-19 Grant 1,000,000 $0.00
Jin David
Common Stock, par value $0.001
2024-10-01 Grant 2,625 $1.23 3,229
Rosenwald Lindsay A MD
Common stock, par value $0.001
2024-09-23 Buy 763,359 $1.84 1,404,581
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 52 5,723,964
2025-12-31 53 6,439,500
2025-09-30 59 4,944,941
2025-06-30 50 4,709,457
2025-03-31 48 5,033,839
2024-12-31 54 4,926,645
2024-09-30 51 4,493,827
2024-06-30 51 3,860,360
2024-03-31 43 3,032,613
2023-12-31 45 5,149,288
2023-09-30 51 22,654,167
2023-06-30 49 24,210,672
Form 13F Holdings
Firm Period DFND Voting Shares
180 Wealth Advisors LLC [2026-06-30] SOLE 43,700 61,600
Abacus Planning Group Inc [2026-06-30] SOLE 0 14,534
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com